Colchicine 0.5 mg for heart diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Coronary Disease

Why this status

  1. 7 Nov 2023: Trial registered, NCT06118034
  2. 28 Jan 2024: Trial started, NCT06118034

The trials

NCT06118034: Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery

State
Under way
Phase
Phase 3
People
768 planned
Started
28 Jan 2024
Primary completion
31 Aug 2026
Arms
Experimental group (colchicine group)
Results
None posted
  1. 7 Nov 2023: Trial registered
  2. 28 Jan 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.